apnimed.comHealthcare / BioTech & PharmaFounded: 2017Funding to Date: $624.05MM
Apnimed, founded in 2017, is a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders. Apnimed’s lead development program targets the neurologic control of upper airway muscles to maintain an open airway during sleep. Based in Cambridge, MA, the company is developing a portfolio of novel pharmacologic therapies for sleep apnea and related disorders.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/22/2022 | Series C-3 | $79.75MM | $xx.xx | $366.58MM | Alpha Wave Ventures, Sectoral Asset Management, Seligman Investments, Tao Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
7,184,033
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Alpha Wave Ventures, Sectoral Asset Management, Seligman Investments, Tao Capital Partners
|
||||||
05/04/2022 | Series C-2 | $25MM | $xx.xx | $268.69MM | Alpha Wave Ventures, Morningside Ventures, Nexpoint, Sectoral Asset Management, Seligman Investments, Tao Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
2,252,042
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Alpha Wave Ventures, Morningside Ventures, Nexpoint, Sectoral Asset Management, Seligman Investments, Tao Capital Partners
|
||||||
05/04/2022 | Series C-1 | $37.5MM | $xx.xx | $268.69MM | Alpha Wave Ventures, Morningside Ventures, Nexpoint, Sectoral Asset Management, Seligman Investments, Tao Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
4,222,581
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Alpha Wave Ventures, Morningside Ventures, Nexpoint, Sectoral Asset Management, Seligman Investments, Tao Capital Partners
|
||||||
03/25/2021 | Series B | $25MM | $xx.xx | $156.17MM | Morningside Venture, Seligman Investments, Tao Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
2,818,964
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Morningside Venture, Seligman Investments, Tao Capital Partners
|
||||||
03/31/2020 | Series A-2 | $15MM | $xx.xx | $98.94MM | Morningside Venture | |
Price per Share
$xx.xx
Shares Outstanding
2,349,108
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Morningside Venture
|
||||||
06/25/2018 | Series A | $25.77MM | $xx.xx | $57.26MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,397,935
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|